Insider · CIK 0001419350

Arcudi III Louis J

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001419350

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-02-26	TPSTTempest Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+400K sh	—	—	400,000
2020-05-25	TPSTTempest Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+80K sh	—	—	80,000
2020-01-31	TPSTTempest Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+71.3K sh	—	—	71,250
2019-06-20	TPSTTempest Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+25K sh	—	—	25,000
2019-01-15	TPSTTempest Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+50K sh	—	—	50,000
2018-12-07	TPSTTempest Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+74.4K sh	—	—	74,400
2018-08-13	Aceragen, Inc.Stock OptionA Award	Chief Financial Officer	AAward	+32.5K sh	—	—	32,500
2018-01-03	Aceragen, Inc.Stock OptionA Award	Chief Financial Officer	AAward	+270K sh	$2.24	+$605K	270,000
2017-01-03	Aceragen, Inc.Stock OptionA Award	Chief Financial Officer	AAward	+185K sh	—	—	185,000
2016-01-06	Aceragen, Inc.Stock OptionA Award	Chief Financial Officer	AAward	+185K sh	—	—	185,000
2014-12-10	Aceragen, Inc.Stock OptionA Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2013-12-10	Aceragen, Inc.Stock OptionA Award	Chief Financial Officer	AAward	+300K sh	—	—	300,000
2013-05-22	Aceragen, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+348K sh	—	—	348,333
2012-11-13	Aceragen, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+33.5K sh	—	—	146,000
2012-03-13	Aceragen, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+12.5K sh	—	—	112,500
2011-12-05	Aceragen, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2011-12-05	Aceragen, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2010-12-27	Aceragen, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+95K sh	—	—	95,000
2009-12-23	Aceragen, Inc.Stock OptionsA Award	Chief Financial Officer	AAward	+110K sh	—	—	110,000
2007-12-03	Aceragen, Inc.Stock OptionsA Award	Chief Financial Officer	AAward	+80K sh	—	—	80,000

Recent filings

Accepted (ET)
Mar 24
Arcudi III Louis J0001544227-21-000010
SEC(opens sec.gov)
May 274
Arcudi III Louis J0001209191-20-032489
SEC(opens sec.gov)
Feb 44
Arcudi III Louis J0001209191-20-006345
SEC(opens sec.gov)
Jun 214
Arcudi III Louis J0001209191-19-038475
SEC(opens sec.gov)
Jan 174
Arcudi III Louis J0001209191-19-004226
SEC(opens sec.gov)
Dec 114
Arcudi III Louis J0001209191-18-062105
SEC(opens sec.gov)
Aug 154
Arcudi III Louis J0001104659-18-052291
SEC(opens sec.gov)
Jan 54
Arcudi III Louis J0001179110-18-000587
SEC(opens sec.gov)
Jan 64
IDERA PHARMACEUTICALS, INC.0001179110-17-000646
SEC(opens sec.gov)
Jan 84
IDERA PHARMACEUTICALS, INC.0001179110-16-017574
SEC(opens sec.gov)
Dec 124
IDERA PHARMACEUTICALS, INC.0001209191-14-075134
SEC(opens sec.gov)
Dec 124
IDERA PHARMACEUTICALS, INC.0001209191-13-056620
SEC(opens sec.gov)
May 244
Arcudi III Louis J0001209191-13-028865
SEC(opens sec.gov)
Nov 154
Arcudi III Louis J0001209191-12-053282
SEC(opens sec.gov)
Mar 154
Arcudi III Louis J0001209191-12-018571
SEC(opens sec.gov)
Dec 74
Arcudi III Louis J0001209191-11-060028
SEC(opens sec.gov)
Dec 284
Arcudi III Louis J0001209191-10-062749
SEC(opens sec.gov)
Dec 244
Arcudi III Louis J0001209191-09-058663
SEC(opens sec.gov)
Dec 44
IDERA PHARMACEUTICALS, INC.0001209191-07-067496
SEC(opens sec.gov)

Companies

Address

C/O IDERA PHARMACEUTICALS, INC. 167 SIDNEY STREET

CAMBRIDGE, MA, 02139